All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Usually Need Help from Another Person for Dressing and Grooming | NCIT_C130972 | [A response indicating that an individual needs help from another person for dressing and grooming.] |
| Usually Need Help from Another Person for Eating | NCIT_C130973 | [A response indicating that an individual needs help from another person for eating.] |
| Genomics of Drug Sensitivity in Cancer | NCIT_C139308 | [Part of a Wellcome Trust funded collaboration between The Cancer Genome Project at the Wellcome Trust Sanger Institute (UK) and the Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center (USA) designed to to improve cancer treatments by discovering therapeutic biomarkers that can be used to identify patients most likely to respond to an anticancer drug.] |
| Usually Need Help from Another Person for Arising | NCIT_C130974 | [A response indicating that an individual needs help from another person for getting up.] |
| Usually Need Help from Another Person for Walking | NCIT_C130975 | [A response indicating that an individual needs help from another person for walking.] |
| Usually Need Help from Another Person for Hygiene | NCIT_C130976 | [A response indicating that an individual needs help from another person for hygiene.] |
| Usually Need Help from Another Person for Reach | NCIT_C130977 | [A response indicating that an individual needs help from another person for reach.] |
| Tis Stage Finding | NCIT_C48738 | [A term that refers to a TNM finding of a primary tumor microscopically defined as carcinoma in situ.] |
| IPSS Risk Category High | NCIT_C139304 | [An International Prognostic Scoring System for Myelodysplastic Syndrome risk category that predicts a high likelihood for progression.] |
| Pathologic TNM Finding | NCIT_C48739 | [TNM staging performed as part of pathologic specimen.] |
| RAS Protein Family Activation Assay | NCIT_C139305 | [An in vitro assay that can indirectly detect the activation of small GTPases in the RAS family through the staining of phosphorylated forms of MEK (MAP2K) family proteins (pMEK). A farnesylated RAS family protein is anchored to an in vitro model of the plasma membrane and, under different conditions, is co-incubated with both a RAF family protein, which binds to and is activated by active RAS proteins, and a MEK family protein, which is phosphorylated by active RAF proteins. pMEK is detected using a donor bead coated with anti-MEK antibodies that is capable of oxidizing an acceptor molecule attached to an anti-pMEK antibody. When the donor and acceptor are in close proximity, the acceptor molecule is oxidized and can be visualized using electron microscopy.] |
| Exascale Computer System | NCIT_C139306 | [Refers to computer systems capable of a quintillion (10^18) calculations each second. This computing power is expected to facilitate the analysis of data sets that would require too much time with currently available systems. Such analysis would allow more realistic simulations of the complex processes and relationships behind many natural processes. This will have practical applications in everything from precision medicine to regional climate, water use to materials science, nuclear physics to national security.] |
| Genomic Data Commons | NCIT_C139307 | [A project of the The National Cancer Institute, the Genomic Data Commons is an expandable knowledge network supporting the import and standardization of genomic and clinical data from cancer research programs in support of precision medicine in oncology.] |
| T4b Stage Finding | NCIT_C48734 | [A general term that refers to a TNM finding of a primary tumor with direct invasion of adjacent structures. The definition of T4b TNM finding depends on the specific type of cancer that it refers to; for example, for bladder cancer it refers to a primary tumor that invades the pelvic wall and abdominal wall; for gastric cancer it refers to a primary tumor that invades adjacent structures; for colorectal cancer it refers to a primary tumor with direct invasion or adherence to other organs or structures.] |
| T4 Stage Finding | NCIT_C48732 | [A clinical and/or pathologic primary tumor TNM finding indicating direct invasion of adjacent structures by cancer.] |
| IPSS Risk Score Greater than or Equal to 2.5 | NCIT_C139300 | [An International Prognostic Scoring System for Myelodysplastic Syndrome risk score greater than or equal to 2.5, corresponding to high risk.] |
| T4c Stage Finding | NCIT_C48735 | [A general term that refers to a TNM finding of a primary tumor with direct invasion of adjacent structures. The definition of T4c TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to a primary tumor that extends to the chest wall, not including the pectoralis muscle, and with edema (including peau d'orange) or ulceration of the skin of the breast or satellite skin nodules confined to the same breast; for ocular adnexal lymphoma it refers to a primary tumor that Involves the maxillofacial, ethmoidal, and/or frontal sinuses; for carcinoma of the conjunctiva it refers to a primary tumor that invades adjacent paranasal sinuses.] |
| IPSS Risk Category Low | NCIT_C139301 | [An International Prognostic Scoring System for Myelodysplastic Syndrome risk category that predicts a low likelihood for progression.] |
| T4d Stage Finding | NCIT_C48736 | [A general term that refers to a TNM finding of a primary tumor with direct invasion of adjacent structures. The definition of T4d TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to a primary tumor that meets the clinical-pathologic criteria of inflammatory carcinoma; for ocular adnexal lymphoma it refers to a primary tumor with intracranial spread; for carcinoma of the conjunctiva it refers to a primary tumor that invades the brain.] |
| IPSS Risk Category Intermediate-1 | NCIT_C139302 | [An International Prognostic Scoring System for Myelodysplastic Syndrome risk category that predicts a low-intermediate likelihood for progression.] |